Due to an increase in cancer cases worldwide, the endoscopic retrograde cholangiopancreatography (ERCP) devices market is projected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032. According to FMI, the market for endoscopic retrograde cholangiopancreatography (ERCP) devices is anticipated to grow at a compound annual growth rate (CAGR) of 6.2% between …